Healthcare provider profile · identity verified

Kyle Matthew Hunt, MD

Family Practice · CAMBRIDGE, MN · NPI 1659834844

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	181
Amlodipine Besylate	Amlodipine Besylate	439	131
Lisinopril	Lisinopril	376	112
Rosuvastatin Calcium	Rosuvastatin Calcium	371	123
Losartan Potassium	Losartan Potassium	328	102
Omeprazole	Omeprazole	308	90
Levothyroxine Sodium	Levothyroxine Sodium	293	77
Eliquis	Apixaban	278	51
Metoprolol Succinate	Metoprolol Succinate	277	91
Hydrochlorothiazide	Hydrochlorothiazide	261	81
Gabapentin	Gabapentin	243	68
Tamsulosin Hcl	Tamsulosin Hcl	209	71
Furosemide	Furosemide	183	58
Metformin Hcl Er	Metformin Hcl	175	61
Trazodone Hcl	Trazodone Hcl	147	45
Ozempic	Semaglutide	144	35
Simvastatin	Simvastatin	144	38
Metformin Hcl	Metformin Hcl	141	41
Albuterol Sulfate Hfa	Albuterol Sulfate	131	52
Fluticasone Propionate	Fluticasone Propionate	118	45
Allopurinol	Allopurinol	117	33
Metoprolol Tartrate	Metoprolol Tartrate	116	38
Irbesartan	Irbesartan	107	29
Pantoprazole Sodium	Pantoprazole Sodium	107	29
Sertraline Hcl	Sertraline Hcl	92	29
Lorazepam	Lorazepam	89	17
Potassium Chloride	Potassium Chloride	88	24
Tizanidine Hcl	Tizanidine Hcl	87	16
Atenolol	Atenolol	86	26
Carvedilol	Carvedilol	85	25
Escitalopram Oxalate	Escitalopram Oxalate	78	28
Duloxetine Hcl	Duloxetine Hcl	77	23
Famotidine	Famotidine	70	21
Citalopram Hbr	Citalopram Hydrobromide	67	21
Warfarin Sodium	Warfarin Sodium	66	20
Alendronate Sodium	Alendronate Sodium	65	21
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	65	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	62	12
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Glipizide Er	Glipizide	57	16
Prednisone	Prednisone	55	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	20
Clopidogrel	Clopidogrel Bisulfate	52	16
Montelukast Sodium	Montelukast Sodium	52	14
Pregabalin	Pregabalin	52	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	12
Triamcinolone Acetonide	Triamcinolone Acetonide	52	33
Donepezil Hcl	Donepezil Hcl	47	12
Bupropion Xl	Bupropion Hcl	46	19
Ezetimibe	Ezetimibe	45	12
Mounjaro	Tirzepatide	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Spironolactone	Spironolactone	42	15
Tramadol Hcl	Tramadol Hcl	42	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	41	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	12
Jardiance	Empagliflozin	40	18
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Finasteride	Finasteride	37	suppressed
Methocarbamol	Methocarbamol	37	14
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Chlorthalidone	Chlorthalidone	36	13
Propranolol Hcl	Propranolol Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Glipizide	Glipizide	35	12
Buspirone Hcl	Buspirone Hcl	34	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	11
Alprazolam	Alprazolam	32	suppressed
Cephalexin	Cephalexin	32	25
Trulicity	Dulaglutide	32	suppressed
Xarelto	Rivaroxaban	31	suppressed
Mirtazapine	Mirtazapine	30	11
Novolog Flexpen	Insulin Aspart	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	11
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	20
Nitroglycerin	Nitroglycerin	27	23
Ondansetron Odt	Ondansetron	27	suppressed
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Azithromycin	Azithromycin	22	17
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Amoxicillin	Amoxicillin	18	11
Advair Diskus	Fluticasone Propion/Salmeterol	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Valacyclovir	Valacyclovir Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	13
Celecoxib	Celecoxib	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Torsemide	Torsemide	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Diphenhydramine Hcl	Diphenhydramine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Estradiol	Estradiol	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error